# Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

> **NCT00758264** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 363 (actual)

## Conditions studied

- Infections, Meningococcal

## Interventions

- **BIOLOGICAL:** Meningococcal vaccine GSK134612
- **BIOLOGICAL:** Pneumococcal vaccine GSK1024850A

## Key facts

- **NCT ID:** NCT00758264
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-30
- **Primary completion:** 2009-06-02
- **Final completion:** 2009-11-02
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758264, "Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00758264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*